Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

BIO International Convention Kickoff Event Highlights Bay Area’s Strong Bioscience Sector & Job Growth

biocon

With just 90 days to go before the ribbon is cut at the BIO International Convention in San Francisco, leading biotech industry executives joined with state and local officials to recognize the industry’s economic impact and highlight many of the special programs and events happening at largest global event for the biotechnology industry. Special thanks to these fine folks for helping us kickoff the countdown to the BIO International Convention, which will be taking place Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Sara Radcliffe: Legislature Shouldn’t Put Hurdles in Way of Cancer Treatments

CLSA

Check out California Life Sciences Association (CLSA) president and chief executive officer Sara Radcliffe’s op-ed that ran in The Sacramento Bee this week. She precisely lays out the concerns and challenges associated with delivering cutting-edge medical therapies to patients.

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Welcomes Seven New Board Members

new-bio-logo

BIO elected seven new members to its Board of Directors, voted upon at this year’s Board Meetings, held this week in New York City. The following individuals were elected to the Health Section Governing Board: Christopher Boerner, President and Head of the U.S. Commercial Business, BMS Mark Alles, President and Chief Operating Officer, Celgene Gary Zieziula, President and Managing Director, EMD Serono Elizabeth Lewis, Chief Counsel and Chief Compliance Officer, Takeda Pharmaceuticals Jean-Christophe Tellier, Chief Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , ,

State Bioscience Groups Discuss Best Practices

CSBA-logo_website

This week the Council of State Bioscience Associations (CSBA) held its annual retreat in Scottsdale, AZ, where over 40 different state-based bioscience advocacy organization gathered to discuss legislative and regulatory best practices that support bioscience industry development. More than 100 invited participants engaged in discussions covering the topics of economic development initiatives, ongoing federal and state legislative industry priorities, and advocacy communications campaigns. BIO’s State Government Relations team would like to extend our gratitude to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Patent Reform in the News

© 2010 Opensourceway (CC 2.0 Attribution ShareAlike) (flickr.com/photos/opensourceway/)

The New York Post and The Washington Post have both run Op-eds in the last week addressing the need to reform the PTO’s inter partes review (IPR) process within current patent reform legislative efforts. Both opinions point to the weakness within the IPR process exposed by short selling practices of predatory hedge fund managers. Click on the links below to read more: From the New York Post: Hedge-fund investors are coming to raid your medicine cabinet. By Peter Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,